“Sense Of Urgency” Motivates AHRQ’s Clancy To Update Health Care Evidence
This article was originally published in The Pink Sheet Daily
Executive Summary
Agency for Healthcare Research and Quality Administrator Clancy speaks with “The Gray Sheet” about the agency's role in comparative effectiveness research and health care reform.
You may also be interested in...
Dueling Comparative Effectiveness Provisions Outlined In Senate Reform Bills
As health reform goes, so goes the effort to establish a long-term infrastructure for comparative effectiveness research in the U.S
Industry Seeks Collaborative Role In HHS Comparative-Effectiveness Research
Industry leaders are urging federal agencies to keep private firms and trade associations in the loop as they make policy decisions regarding comparative-effectiveness research
CMS Urged To Cover Beta Amyloid PET Scans For Alzheimer's, But Cautiously
Imaging stakeholders call for Medicare coverage of beta amyloid positron emission tomography scans to help diagnose and manage dementia patients, but clinical societies warn against using the technology as a screening tool for Alzheimer’s disease. CMS took comments through Nov. 8 on its ongoing national coverage analysis.